The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SORAVE: A phase I trial to evaluate safety and efficacy of combination therapy with everolimus and sorafenib.
 
Christian Mattonet
No Relationships to Disclose
 
Lucia Nogova
Honoraria - Amgen; Roche Pharma AG
 
Matthias Scheffler
Consulting or Advisory Role - Novartis
 
Sebastian Yves Friedrich Michels
Honoraria - AstraZeneca; Boehringer Ingelheim; Novartis
 
Deniz Kahraman
No Relationships to Disclose
 
Carsten Kobe
No Relationships to Disclose
 
Uwe Fuhr
Honoraria - CRS Cinical Research Services
Consulting or Advisory Role - Janssen-Cilag; Neuss, Germany
Research Funding - InfectoPharm
 
Ahmed Abbas Suleiman
No Relationships to Disclose
 
Yingying Tian
No Relationships to Disclose
 
Fritz Soergel
No Relationships to Disclose
 
Karin Toepelt
No Relationships to Disclose
 
Roland Schnell
No Relationships to Disclose
 
Max Schlaak
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Kerstin Rhiem
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
 
Reinhard Buettner
Consulting or Advisory Role - GlaxoSmithKline; Merck Serono; Novartis; Pfizer; Qiagen; Roche Pharma AG
 
Juergen Wolf
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Novartis; Pfizer; Roche Pharma AG
Research Funding - Bayer; Boehringer Ingelheim; Novartis; Pfizer; Roche Pharma AG